AKT1 and cancer: In addition, the abnormality of the PI3K-AKT signaling pathway is the most common genomic abnormality in breast, ovarian, bladder, and other cancers (Serra et al., 2008; Aziz et al., 2018; Costa et al., 2018; Liu et al., 2018).